STA Pharmaceutical, a WuXi AppTec subsidiary, has expanded its new integrated R&D and commercial site in Changzhou, China, to 200 process R&D scientists and added a new pilot plant. The site, which was officially opened in March 2016, has grown to over 200 scientific personal including 160 process chemists, 40 analytical chemists, and a special group of crystallization technology engineers having been trained for over a year at the company’s Shanghai R&D facility. The 10,000 squar...